# Using E-Nose Technology to Track Treatment Response in People With Non-Small Cell Lung Cancer

> **NCT07218601** · PHASE2 · RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 60 (estimated)

## Conditions studied

- Non-Small Cell Lung Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Breath sample collection
- **DIAGNOSTIC_TEST:** Research blood collection

## Key facts

- **NCT ID:** NCT07218601
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-10
- **Primary completion:** 2027-10
- **Final completion:** 2027-10
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07218601

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07218601, "Using E-Nose Technology to Track Treatment Response in People With Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT07218601. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*